Correction to: Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior (Molecular Psychiatry, (2014), 19, 10, (1078-1084), 10.1038/mp.2014.102);Striatal dopamine D2-like receptor correlation patterns with human obesity and opportunistic eating behavior

Molecular Psychiatry

Volumn 19, Issue 10, 2014, Pages 1078-1084

  Guo, J ^a   Simmons, W K ^b,c   Herscovitch, P ^d   Martin, A ^e   Hall, K D ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^c UNIVERSITY OF TULSA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; FALLYPRIDE F 18; FLUORINE 18; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; N-((1-ALLYL-2-PYRROLIDINYL)METHYL)-5-(3-FLUOROPROPYL)-2,3-DIMETHOXYBENZAMIDE; PYRROLIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADULT; ANTERIOR COMMISSURE; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY BALANCE; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GLOBUS PALLIDUS; HUMAN; INSULIN RESISTANCE; LEFT HEMISPHERE; MALE; OBESITY; OPPORTUNISTIC EATING BEHAVIOR; OVERNUTRITION; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; VENTRAL PALLIDUM; VENTRAL STRIATUM; CORPUS STRIATUM; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; SCINTISCANNING;

ADULT; BENZAMIDES; CORPUS STRIATUM; FEEDING BEHAVIOR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OBESITY; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D2;

EID: 84908008130     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/s41380-022-01767-5     Document Type: Erratum

References (30)

1. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 2011; 378: 804-814.
2. Bond MJ, McDowell AJ, Wilkinson JY. The measurement of dietary restraint, disinhibition and hunger: an examination of the factor structure of the Three Factor Eating Questionnaire (TFEQ). Int J Obes Relat Metab Disord 2001; 25: 900-906.
3. Bryant EJ, King NA, Blundell JE. Disinhibition: its effects on appetite and weight regulation. Obes Rev 2008; 9: 409-419.
4. Graybiel AM. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008; 31: 359-387.
5. Wickens JR, Horvitz JC, Costa RM, Killcross S. Dopaminergic mechanisms in actions and habits. J Neurosci 2007; 27: 8181-8183.
6. Yin HH, Knowlton BJ. The role of the basal ganglia in habit formation. Nat Rev Neurosci 2006; 7: 464-476.
7. Yin HH, Ostlund SB, Balleine BW. Reward-guided learning beyond dopamine in the nucleus accumbens: the integrative functions of cortico-basal ganglia networks. Eur J Neurosci 2008; 28: 1437-1448.
8. Nelson A, Killcross S. Amphetamine exposure enhances habit formation. J Neurosci 2006; 26: 3805-3812.
9. Faure A, Haberland U, Conde F, El Massioui N. Lesion to the nigrostriatal dopamine system disrupts stimulus-response habit formation. J Neurosci 2005; 25: 2771-2780.
10. Murray JE, Dilleen R, Pelloux Y, Economidou D, Dalley JW, Belin D et al. Increased impulsivity retards the transition to dorsolateral striatal dopamine control of cocaine seeking. Biol Psychiatry 2014; 76: 15-22.
11. Yin HH, Knowlton BJ, Balleine BW. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J Neurosci 2004; 19: 181-189.
12. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W et al. Brain dopamine and obesity. Lancet 2001; 357: 354-357.
13. Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res 2010; 1350: 43-64.
14. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985; 29: 71-83.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
16. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. NeuroImage 1996; 4: 153-158.
17. Berthoud HR. The neurobiology of food intake in an obesogenic environment. Proc Nutr Soc 2012; 71: 478-487.
18. Rangel A. Regulation of dietary choice by the decision-making circuitry. Nature Neurosci 2013; 16: 1717-1724.
19. Volkow ND, Wang GJ, Tomasi D, Baler RD. The addictive dimensionality of obesity. Biol Psychiatry 2013; 73: 811-818.
20. Caravaggio F, Raitsin S, Gerretsen P, Nakajima S, Wilson A, Graff-Guerrero A. Ventral striatum binding of a dopamine D receptor agonist but not antagonist predicts normal body mass index. Biol Psychiatry 2013. e-pub ahead of print 27 March 2013. doi:10.1016/j.biopsych.2013.02.017.
21. Eisenstein SA, Antenor-Dorsey JA, Gredysa DM, Koller JM, Bihun EC, Ranck SA et al. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[C]methyl)benperidol. Synapse 2013; 67: 748-756.
22. Steele KE, Prokopowicz GP, Schweitzer MA, Magunsuon TH, Lidor AO, Kuwabawa H et al. Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg 2010; 20: 369-374.
23. de Weijer BA, van de Geissen E, van Amelsvoort TA, Boot E, Braak B, Janssen IM et al. Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects. EJNMMI Res 2011; 1: 37.
24. Haltia LT, Rinne JO, Merisaari H, Maguire RP, Savontaus E, Helin S et al. Effects of intravenous glucose on dopaminergic function in the human brain in vivo. Synapse 2007; 61: 748-756.
25. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. NeuroImage 2003; 19: 1709-1715.
26. Elsinga PH, Hatano K, Ishiwata K. PET tracers for imaging of the dopaminergic system. Curr Med Chem 2006; 13: 2139-2153.
27. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000; 97: 8104-8109.
28. Morris ED, Yoder KK. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics. J Cereb Blood Flow Metab 2007; 27: 606-617.
29. Alsio J, Olszewski PK, Norback AH, Gunnarsson ZE, Levine AS, Pickering C et al. Dopamine D1 receptor gene expression decreases in the nucleus accumbens upon long-term exposure to palatable food and differs depending on diet-induced obesity phenotype in rats. Neuroscience 2010; 171: 779-787.
30. Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nature Neurosci 2010; 13: 635-641.